Mary Connolly

Author PubWeight™ 39.51‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies. Bipolar Disord 2005 4.94
2 Pyridoxine responsiveness in novel mutations of the PNPO gene. Neurology 2014 2.38
3 The spectrum of SCN1A-related infantile epileptic encephalopathies. Brain 2007 2.30
4 Pyridoxine dependent epilepsy and antiquitin deficiency: clinical and molecular characteristics and recommendations for diagnosis, treatment and follow-up. Mol Genet Metab 2011 1.61
5 90Y-edotreotide for metastatic carcinoid refractory to octreotide. J Clin Oncol 2010 1.49
6 HPV detection rate in discordant Pap tests between cytotechnologists and pathologists. Diagn Cytopathol 2009 1.39
7 Human rheumatoid arthritis tissue production of IL-17A drives matrix and cartilage degradation: synergy with tumour necrosis factor-alpha, Oncostatin M and response to biologic therapies. Arthritis Res Ther 2009 1.28
8 A direct test of potential roles for beta3 and beta5 integrins in growth and metastasis of murine mammary carcinomas. Cancer Res 2005 1.08
9 Oncostatin M induces angiogenesis and cartilage degradation in rheumatoid arthritis synovial tissue and human cartilage cocultures. Arthritis Rheum 2006 1.04
10 Blockade of Toll-like receptor 2 prevents spontaneous cytokine release from rheumatoid arthritis ex vivo synovial explant cultures. Arthritis Res Ther 2011 1.03
11 Toll-like receptor 2 induced angiogenesis and invasion is mediated through the Tie2 signalling pathway in rheumatoid arthritis. PLoS One 2011 0.94
12 Lysine restricted diet for pyridoxine-dependent epilepsy: first evidence and future trials. Mol Genet Metab 2012 0.93
13 A role for the high-density lipoprotein receptor SR-B1 in synovial inflammation via serum amyloid-A. Am J Pathol 2010 0.92
14 Surgical outcome in tuberous sclerosis complex: a multicenter survey. Epilepsia 2007 0.92
15 Interleukin-17A induction of angiogenesis, cell migration, and cytoskeletal rearrangement. Arthritis Rheum 2011 0.89
16 Notch-1 mediates hypoxia-induced angiogenesis in rheumatoid arthritis. Arthritis Rheum 2012 0.89
17 Phase I trial of 90Y-DOTATOC therapy in children and young adults with refractory solid tumors that express somatostatin receptors. J Nucl Med 2010 0.88
18 Notch-1 mediates endothelial cell activation and invasion in psoriasis. Exp Dermatol 2014 0.87
19 Effects of AiiA-mediated quorum quenching in Sinorhizobium meliloti on quorum-sensing signals, proteome patterns, and symbiotic interactions. Mol Plant Microbe Interact 2007 0.87
20 An intervention fidelity framework for technology-based behavioral interventions. Nurs Res 2011 0.86
21 Evaluating the clinical effectiveness of 90Y-SMT 487 in patients with neuroendocrine tumors. J Nucl Med 2003 0.86
22 Preserved episodic memory in subcortical band heterotopia. Epilepsia 2004 0.85
23 Redox-mediated angiogenesis in the hypoxic joint of inflammatory arthritis. Arthritis Rheumatol 2014 0.85
24 New antiepileptic drug therapies. Neurol Clin 2002 0.83
25 Clinical trials of health information technology interventions intended for patient use: unique issues and considerations. Clin Trials 2013 0.83
26 Outcomes trajectories in children with epilepsy: hypotheses and methodology of a Canadian longitudinal observational study. Pediatr Neurol 2014 0.83
27 Tumor necrosis factor inhibition modulates thrombospondin-1 expression in human inflammatory joint disease through altered NR4A2 activity. Am J Pathol 2013 0.80
28 Effects of intravenous amino acid administration with Y-90 DOTA-Phe1-Tyr3-Octreotide (SMT487[OctreoTher) treatment. Cancer Biother Radiopharm 2004 0.80
29 Safety huddles in the PACU: when a patient self-medicates. J Perianesth Nurs 2011 0.79
30 Quality of recipient-caregiver relationship and psychological distress are correlates of self-care agency after lung transplantation. Clin Transplant 2012 0.79
31 Cerebral sinus thrombosis following IV immunoglobulin therapy of immune thrombocytopenia purpura. Pediatr Blood Cancer 2011 0.79
32 Autosomal recessive GTP cyclohydrolase I deficiency without hyperphenylalaninemia: evidence of a phenotypic continuum between dominant and recessive forms. Mol Genet Metab 2008 0.78
33 Epilepsy with occipital features in children: factors predicting seizure outcome and neuroimaging abnormalities. Eur J Paediatr Neurol 2010 0.77
34 Pharmacological management of a youth with ADHD and a seizure disorder. J Am Acad Child Adolesc Psychiatry 2006 0.77
35 Risperidone in acute and continuation treatment of mania. Int Clin Psychopharmacol 2003 0.77
36 Urgent, resective surgery for medically refractory, convulsive status epilepticus. Eur J Paediatr Neurol 2008 0.76
37 Is the serum amyloid A we use really serum amyloid A? Comment on the article by Connolly et al. Reply. Arthritis Rheum 2013 0.75
38 Diagnostic value of a multidisciplinary clinic for intellectual disability. Can J Neurol Sci 2014 0.75
39 Assessment of hepatic toxicity from treatment with 90Y-SMT 487 (OctreoTher(TM)) in patients with diffuse somatostatin receptor positive liver metastases. Cancer Biother Radiopharm 2003 0.75
40 Protocol for Symptom Experience, Management, Outcomes, and Adherence in Women Receiving Breast Cancer Chemotherapy. Nurs Res 1 0.75
41 Landau-Kleffner syndrome: a rare auditory processing disorder series of cases and review of the literature. Int J Pediatr Otorhinolaryngol 2010 0.75